HemaSphere
ISSN: 2572-9241
Publisher: Lippincott, Williams & Wilkins
Publications (14)
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025)
Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al.
Journal article
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience (2024)
Innocenti I, Mosca A, Tomasso A, Galitzia A, Scarfò L, Morelli F, Galli E, et al.
Journal article
How to put a hex on HOX (2024)
Slany R
Journal article
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade (2024)
Schewe DM, Vogiatzi F, Münnich IA, Zeller T, Windisch R, Wichmann C, Müller K, et al.
Journal article
Models for the marrow: A comprehensive review of AI-based cell classification methods and malignancy detection in bone marrow aspirate smears. (2024)
Ghete T, Kock F, Pontones M, Pfrang D, Westphal M, Höfener H, Metzler M
Journal article, Review article
Inferior Outcomes of EU Versus US Patients Treated with CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association with Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use (2023)
Bücklein V, Perez A, Rejeski K, Iacoboni G, Jurinovic V, Holtick U, Penack O, et al.
Journal article
Identifying Early Infections in the Setting of CRS with Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL (2023)
Rejeski K, Blumenberg V, Iacoboni G, Lopez-Corral L, Kharboutli S, Hernani R, Petrera A, et al.
Journal article
The eha research roadmap: Infections in hematology (2021)
Cordonnier C, Ljungman P, Cesaro S, Hirsch HH, Maschmeyer G, Von Lilienfeld-Toal M, Vehreschild M, et al.
Journal article, Review article
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future (2021)
Heine R, Thielen FW, Koopmanschap M, Kersten MJ, Einsele H, Jaeger U, Sonneveld P, et al.
Journal article
The EHA research Roadmap: Immune-based therapies for hematological malignancies (2021)
Einsele H, Briones J, Ciceri F, Garcia Cadenas I, Falkenburg F, Bolanos N, Heemskerk HMM, et al.
Journal article, Review article